- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01839305
Effects of Hydrotherapy on Physical Function and Quality of Life of Women With Fibromyalgia
June 23, 2016 updated by: Mariana Arias Avila
Effects of Hydrotherapy on 3D Scapular Kinematics, Electromyography, Pain, Quality of Life, Balance and Cardiorespiratory Variables in Women With Fibromyalgia
Fibromyalgia Syndrome (FS) is one condition that most affects functional performance, especially in women, due to alterations in the entire musculoskeletal system.
Given that, Physical Therapy (PT) studies the human movement and its dysfunctions, and that FS, because of its complex chronic characteristic, impairs the affected individual's activities causing movement disorders, a PT professional must be part of the multidisciplinary team involved in the FS treatment.
Nonetheless, as explained in the present proposal, several aspects still need clarification related to the PT role in this syndrome.
Particularly, studies that analyze the biomechanical, sensorial and cardiorespiratory adaptations in individuals who undergo PT intervention still lack; those studies would contribute with scientific evidence to the clinical practice.
According to recent systematic reviews, one of the most used therapies with positive effects on FS subjects is the hydrotherapy, which combines exercises and the water relaxing effects.
Other alternative treatments have also been searched, in an attempt to decrease the painful picture presented, as the FS etiology and pathophysiology are not well known.
The aim of this study is to evaluate the efficacy of different physical therapy resources in the FS, in two subprojects.
The first will verify if hydrotherapy is effective in modifying movement variables (scapular kinematics and electromyography) and autonomic modulation.
Other variables, such as pain level and quality of life in women with FS, will also be analyzed.
The second study will evaluate the efficacy of the Shiatsu massage on pain, sleep quality, balance and quality of life of subjects with FS.
Study Overview
Detailed Description
Subjects were invited to take part in several assessments before starting the actual Hydrotherapy Treatment. These assessments were:
- Three-dimensional scapular evaluation
- Questionnaires (FIQ, SF-36, Beck Depression Inventory, Beck Anxiety Inventory, Pittsburgh Quality of Sleep Index)
- Pain (pressure pain threshold and trigger points) Subjects were evaluated 3 times one month before starting treatment, one time in the middle of treatment and after treatment completion.
Treatment lasted 16 weeks and consisted of 2 weekly 45' hydrotherapy sessions.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
SP
-
São Carlos, SP, Brazil, 13562-003
- Academia O2
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- to have a clinical fibromyalgia diagnosis according to the 1990 ACR criteria
- to be aged from 30 to 60 years old.
Exclusion Criteria:
- Body Mass index >28kg/m²
- Cognitive deficits that prevented patients to understand the evaluation procedures
- Uncontrolled systemic illnesses (e.g. diabetes mellitus and systemic arterial hypertension)
- Neurological and musculoskeletal conditions that could have directly interfered in the evaluations, as paresis, important sensitive alterations, advanced joint diseases (e.g. arthroplasties or osteoarthritis)
- Infections
- Urinary incontinence
- Pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Hidrotherapy
Patients performed hydrotherapy 2 twice a week, for 16 weeks, to check if there was any effect on the outcome measures for women with fibromyalgia
|
Hydrotherapy, monitored by physical therapists, performed in groups of up to 10 volunteers, for 45 min per session, twice a week, for 16 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain
Time Frame: up to 5 months from the initial interview
|
Pain will be assessed as a composite measure through Visual Analogue Scale (VAS), Numerical Pain Rating Scale (NPRS), Myofascial Trigger Points (MTrPs) and Pressure Pain Threshold (PPT) on specific sites.
|
up to 5 months from the initial interview
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
3D Kinematics and electromyography
Time Frame: up to 5 months from the initial interview
|
3D kinematics and electromyography will be evaluated with Flock of Birds, Motion Monitor Software and Delsys EMG Device
|
up to 5 months from the initial interview
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Balance
Time Frame: up to 5 months from the initial interview
|
Balance will be assessed by a force platform, in which patients will have to stand up still in some specific positions.
|
up to 5 months from the initial interview
|
|
Function
Time Frame: up to 5 months from the initial interview
|
Funtion will be assessed as a composite measure that includes questionnaires to evaluate different varibales that could be related to function: Fibromyalgia Impact Questionnaire, SF-36, Beck Depression Inventory, Beck Anxiety Inventory and Pittsburgh Sleep Quality Index.
|
up to 5 months from the initial interview
|
|
Cardiorespiratory Status
Time Frame: up to 5 months from initial interview
|
Cardiorespiratory status will be assessed by the heart rate variability, the ECG and the ergometric test
|
up to 5 months from initial interview
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Tania F Salvini, PhD, Ufscar
- Principal Investigator: Antonio Roberto Zamunér, MSc, Ufscar
- Principal Investigator: Deborah C Trevisan, MSc, Ufscar
- Study Chair: Ester Silva, PhD, Ufscar
- Study Chair: Paula R Camargo, PhD, Ufscar
- Study Chair: Patricia Driusso, PhD, Ufscar
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2011
Primary Completion (Actual)
April 1, 2013
Study Completion (Actual)
March 1, 2014
Study Registration Dates
First Submitted
April 17, 2013
First Submitted That Met QC Criteria
April 19, 2013
First Posted (Estimate)
April 24, 2013
Study Record Updates
Last Update Posted (Estimate)
June 24, 2016
Last Update Submitted That Met QC Criteria
June 23, 2016
Last Verified
June 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 485/2011
- FAPESP (Other Grant/Funding Number: 2010/50120-4)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibromyalgia
-
Ionclinics & Deionic SLHospital Clínico Universitario de ValenciaNot yet recruitingFibromyalgia (FM)Spain
-
Ain Shams UniversityRecruiting
-
Selcuk UniversityNot yet recruiting
-
Fundació Institut de Recerca de l'Hospital de la...CompletedFibromyalgia (FM)Spain
-
Istanbul Gelisim UniversityBahçeşehir UniversityCompleted
-
Gazi UniversityCompletedFibromyalgia SyndromeTurkey (Türkiye)
-
University of UtahRecruitingFibromyalgia (FM)United States
-
María Catalina Osuna PérezActive, not recruitingFibromyalgia SyndromeSpain
-
Istanbul UniversityCompletedFibromyalgia | Fibromyalgia Syndrome | Fibromyalgia (FM)Turkey (Türkiye)
Clinical Trials on Hydrotherapy
-
Pierre Fabre Dermo CosmetiqueCompletedChronic Pruritus Due to Plaque PsoriasisSpain, France
-
University of ThessalyCompleted
-
Lancashire Teaching Hospitals NHS Foundation TrustDuchenne UKActive, not recruiting
-
Hadassah Medical OrganizationCompletedOsteoarthritis | Total Knee ReplacementIsrael
-
Chinese University of Hong KongCompleted
-
Kırklareli UniversityCompleted
-
Eggensberger OHGBavarian Health and Food Safety Authority (LGL)RecruitingPost COVID-19 Condition | Post COVID-19 | Post COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID-19 Condition (PCC)Germany
-
Cairo UniversityRecruitingPostmenopausal WomenEgypt
-
vandfysHerlev and Gentofte HospitalCompleted
-
Kafrelsheikh UniversityCompleted